Issue 48, 2022

Co-crystals of zwitterionic GABA API's pregabalin and phenibut: properties and application

Abstract

We present several multicomponent crystalline species formed by zwitterionic GABA analogues pregabalin and phenibut. These compounds are evaluated based on their crystal structure in congruence with properties such as melting behaviour, solubility, and lattice energies. Furthermore, it is discussed how major property distinctions between a homo- and heterochiral co-crystalline system enable enantiopurification of pregabalin.

Graphical abstract: Co-crystals of zwitterionic GABA API's pregabalin and phenibut: properties and application

Supplementary files

Article information

Article type
Paper
Submitted
13 Oct 2022
Accepted
17 Nov 2022
First published
17 Nov 2022
This article is Open Access
Creative Commons BY license

CrystEngComm, 2022,24, 8390-8398

Co-crystals of zwitterionic GABA API's pregabalin and phenibut: properties and application

D. Komisarek, T. Haj Hassani Sohi and V. Vasylyeva, CrystEngComm, 2022, 24, 8390 DOI: 10.1039/D2CE01416E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements